Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) | Finanzwire

Basculer en Français

11096	Companies
243920	Keywords
172040	Articles
131423	Press releases

Headlines Articles Press releases Aspire Biopharma Holdings, Inc.

Home
Companies
Aspire Biopharma Holdings, Inc.

BRIEF

published on 09/03/2025 at 14:35, 1 year ago

Aspire Biopharma Achieves Key Milestone with Sublingual Aspirin Trial for Heart Attack Treatment

FDA Approval Clinical Trial Sublingual Aspirin Heart Attack Treatment Thromboxane B2 Inhibition
PRESS RELEASE

published on 09/03/2025 at 14:30, 1 year ago

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Aspire's sublingual aspirin formulation rapidly inhibits blood clotting by blocking platelet aggregation, showing potential for accelerated approval in Q3 2025

Clinical Trial Sublingual Aspirin Aspire TxB2 Inhibition Heart Attack
BRIEF

published on 08/13/2025 at 15:15, 1 year 1 month ago

Aspire Biopharma Launches BUZZ BOMB™ Pre-Workout Supplement

Consumer Outreach Aspire Biopharma Pre-workout Supplement Fitness Conventions BUZZ BOMB™ Launch
PRESS RELEASE

published on 08/13/2025 at 15:10, 1 year 1 month ago

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Aspire's BUZZ BOMB™ sublingual pre-workout supplement with 50mg of caffeine in four flavors showcased at FitCon and FitExpo, impressing fitness experts and consumers for its rapid delivery technology and convenience

Aspire Sublingual BUZZ BOMB FITCON Pre-workout

Accesswire

Published on 09/30/2026 at 02:05, 4 hours 35 minutes ago

Annual Report for the Year Ended 30 June 2026
Published on 09/30/2026 at 01:45, 4 hours 55 minutes ago

Tungsten Eagle Development Corp. (Formerly Patriot Resources Corp.) Completes Fundamental Change, Closes $5,000,000 Concurrent Financing and to Commence Trading on the Canadian Securities Exchange
Published on 09/30/2026 at 00:55, 5 hours 45 minutes ago

Core Silver Announces Private Placement of up to $1,000,000
Published on 09/30/2026 at 00:45, 5 hours 55 minutes ago

Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 2026
Published on 09/29/2026 at 23:20, 7 hours 20 minutes ago

EvokAI Creative Labs to Transfer Listing to NEX

View all ACCESSWIRE

EQS Group

Published on 09/30/2026 at 06:30, 10 minutes ago

Change of Leadership at Rieter Ad-hoc announcement pursuant to Art. 53 LR
Published on 09/30/2026 at 00:05, 6 hours 35 minutes ago

New study reveals major impact of climate change on skin health worldwide
Published on 09/30/2026 at 00:05, 6 hours 35 minutes ago

Almost 95% of viral Korean skincare and 'glass skin' TikTok videos contain misleading claims, new study shows
Published on 09/29/2026 at 21:30, 9 hours 10 minutes ago

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Published on 09/29/2026 at 19:47, 10 hours 53 minutes ago

EQS-Adhoc: Marley Spoon Group SE: MARLEY SPOON GROUP SE REPORTS H1 2026 RESULTS AND GUIDANCE FOR 2026

Les Echos

Published on 09/28/2026 at 17:54, 1 day 12 hours ago

Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:45, 1 day 12 hours ago

Weekly share buyback
Published on 09/28/2026 at 17:35, 1 day 13 hours ago

Disclosure of transactions in own shares from September 21 to September 25, 2026
Published on 09/28/2026 at 08:45, 1 day 21 hours ago

BAIKOWSKI: 2026 first-half results
Published on 09/28/2026 at 08:02, 1 day 22 hours ago

Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom

View all LES ECHOS COMFI WIRE